Integration Reality Check: When ERP, MES, And LIMS Interfaces Help—And When They Stall Your Go-Live
Core CMMS and EAM functionality in a regulated environment can run compliantly on its own. The delays tend to come from the interfaces stakeholders insist on adding along the way. This article works through the compounding math of interface growth and its tie to Annex 11 and FDA's updated CSA guidance. It sets out three criteria an integration must meet to earn a place in Phase 1, describes the stall patterns that recur in regulated implementations, and explains why one-directional feeds make a safer starting point. It also introduces the idea of treating each interface as its own mini-validation, with a worked example. A four-step plan for sequencing the work rounds it out. Read on to see how to draw the line for your own project.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.